| | | | | |
ECF Ellsworth Growth and Income Fund Ltd | €10,7632 | +1,81% | €144,98M | €11,12K | |
SBFG SB Financial Group, Inc. | €23,1682 | +1,48% | €144,58M | €21,75K | |
| €4,8300 | -0,71% | €144,52M | €73,20K | |
QTRX Quanterix Corporation Common Stock | €3,2359 | +7,04% | €144,04M | €292,50K | |
| €3,7528 | +0,00% | €143,91M | €48,49K | |
CTAA ClearThink 1 Acquisition Corp. Class A Ordinary Shares | €8,6436 | +0,30% | €143,50M | €6,080 | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | €8,9563 | +0,10% | €142,90M | €7,818 | |
EDF Virtus Stone Harbor Emerging Markets Income Fund | €4,4825 | -0,77% | €142,89M | €157,72K | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | €1,4768 | -1,16% | €142,78M | €434,60K | |
| €1,8590 | +4,90% | €142,70M | €125,88K | |
APYX Apyx Medical Corporation Common Stock | €3,6138 | +1,46% | €142,30M | €127,99K | |
ARCT Arcturus Therapeutics Holdings Inc. Common Stock | €5,2035 | +3,99% | €142,22M | €191,81K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,8049 | -0,91% | €142,06M | €92,33K | |
MNSB MainStreet Bancshares, Inc. Common Stock | €20,3102 | +1,39% | €141,65M | €22,28K | |
KORE KORE Group Holdings, Inc. | €6,9496 | -13,50% | €141,60M | €104,24 | |
